269 related articles for article (PubMed ID: 32179631)
1. Compound kushen injection relieves tumor-associated macrophage-mediated immunosuppression through TNFR1 and sensitizes hepatocellular carcinoma to sorafenib.
Yang Y; Sun M; Yao W; Wang F; Li X; Wang W; Li J; Gao Z; Qiu L; You R; Yang C; Ba Q; Wang H
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32179631
[TBL] [Abstract][Full Text] [Related]
2. A metabolic data-driven systems pharmacology strategy for decoding and validating the mechanism of Compound Kushen Injection against HCC.
Wang KX; Chen YP; Lu AP; Du GH; Qin XM; Guan DG; Gao L
J Ethnopharmacol; 2021 Jun; 274():114043. PubMed ID: 33753143
[TBL] [Abstract][Full Text] [Related]
3. Rebalancing TGF-β/Smad7 signaling via Compound kushen injection in hepatic stellate cells protects against liver fibrosis and hepatocarcinogenesis.
Yang Y; Sun M; Li W; Liu C; Jiang Z; Gu P; Li J; Wang W; You R; Ba Q; Li X; Wang H
Clin Transl Med; 2021 Jul; 11(7):e410. PubMed ID: 34323416
[TBL] [Abstract][Full Text] [Related]
4. Bis-benzylidine Piperidone RA190 treatment of hepatocellular carcinoma via binding RPN13 and inhibiting NF-κB signaling.
Soong RS; Anchoori RK; Roden RBS; Cho RL; Chen YC; Tseng SC; Huang YL; Liao PC; Shyu YC
BMC Cancer; 2020 May; 20(1):386. PubMed ID: 32375699
[TBL] [Abstract][Full Text] [Related]
5. Withaferin A, a natural thioredoxin reductase 1 (TrxR1) inhibitor, synergistically enhances the antitumor efficacy of sorafenib through ROS-mediated ER stress and DNA damage in hepatocellular carcinoma cells.
Chen X; Zhu N; Wu Y; Zhang Y; Zhang Y; Jin K; Zhou Z; Chen G; Wang J
Phytomedicine; 2024 Jun; 128():155317. PubMed ID: 38537439
[TBL] [Abstract][Full Text] [Related]
6. Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages.
Ou DL; Chen CW; Hsu CL; Chung CH; Feng ZR; Lee BS; Cheng AL; Yang MH; Hsu C
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33753566
[TBL] [Abstract][Full Text] [Related]
7. The Combination of R848 with Sorafenib Enhances Antitumor Effects by Reprogramming the Tumor Immune Microenvironment and Facilitating Vascular Normalization in Hepatocellular Carcinoma.
He Y; Zhan L; Shi J; Xiao M; Zuo R; Wang C; Liu Z; Gong W; Chen L; Luo Y; Zhang S; Wang Y; Chen L; Guo H
Adv Sci (Weinh); 2023 Jun; 10(18):e2207650. PubMed ID: 37083239
[TBL] [Abstract][Full Text] [Related]
8. Herbal formula of Bushen Jianpi combined with sorafenib inhibits hepatocellular carcinoma growth by promoting cell apoptosis and blocking the cell cycle.
Zhou Z; Liu X; Wu T; Que Z; Wu Z; Wu W; Fu S; Zhang S; Yang Y; Jiang H; Xia X; Lv J; Du B; Li Y; Lu T; Zhang Z; Zhong Y
J Tradit Chin Med; 2021 Apr; 41(2):194-202. PubMed ID: 33825398
[TBL] [Abstract][Full Text] [Related]
9. Sorafenib and Carfilzomib Synergistically Inhibit the Proliferation, Survival, and Metastasis of Hepatocellular Carcinoma.
Jiang C; Xu R; Li XX; Zhou YF; Xu XY; Yang Y; Wang HY; Zheng XFS
Mol Cancer Ther; 2018 Dec; 17(12):2610-2621. PubMed ID: 30224431
[TBL] [Abstract][Full Text] [Related]
10. Vinorelbine Improves the Efficacy of Sorafenib against Hepatocellular Carcinoma: A Promising Therapeutic Approach.
Ng WH; Soo KC; Huynh H
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338842
[TBL] [Abstract][Full Text] [Related]
11. Targeted Therapy for Hepatocellular Carcinoma: Co-Delivery of Sorafenib and Curcumin Using Lactosylated pH-Responsive Nanoparticles.
Bian Y; Guo D
Drug Des Devel Ther; 2020; 14():647-659. PubMed ID: 32109990
[TBL] [Abstract][Full Text] [Related]
12. Recombinant adenovirus expressing the fusion protein PD1PVR improves CD8
Zhang H; Zhang Y; Dong J; Zuo S; Meng G; Wu J; Wei J
Cell Oncol (Dordr); 2021 Dec; 44(6):1243-1255. PubMed ID: 34491549
[TBL] [Abstract][Full Text] [Related]
13. OATP1B1 Plays an Important Role in the Transport and Treatment Efficacy of Sorafenib in Hepatocellular Carcinoma.
Wen J; Zhao M
Dis Markers; 2021; 2021():9711179. PubMed ID: 34721737
[TBL] [Abstract][Full Text] [Related]
14. SUMOylation inhibitors activate anti-tumor immunity by reshaping the immune microenvironment in a preclinical model of hepatocellular carcinoma.
Wang Z; Pan B; Su L; Yu H; Wu X; Yao Y; Zhang X; Qiu J; Tang N
Cell Oncol (Dordr); 2024 Apr; 47(2):513-532. PubMed ID: 38055116
[TBL] [Abstract][Full Text] [Related]
15. Burning down the house: Pyroptosis in the tumor microenvironment of hepatocellular carcinoma.
Cheng C; Hsu SK; Chen YC; Liu W; Shu ED; Chien CM; Chiu CC; Chang WT
Life Sci; 2024 Jun; 347():122627. PubMed ID: 38614301
[TBL] [Abstract][Full Text] [Related]
16. Targeted degradation of NDUFS1 by agrimol B promotes mitochondrial ROS accumulation and cytotoxic autophagy arrest in hepatocellular carcinoma.
Dong L; Luo L; Wang Z; Lian S; Wang M; Wu X; Fan J; Zeng Y; Li S; Lv S; Yang Y; Chen R; Shen E; Yang W; Li C; Wang K
Free Radic Biol Med; 2024 Aug; 220():111-124. PubMed ID: 38697493
[TBL] [Abstract][Full Text] [Related]
17. HRG switches TNFR1-mediated cell survival to apoptosis in Hepatocellular Carcinoma.
Zou X; Zhang D; Song Y; Liu S; Long Q; Yao L; Li W; Duan Z; Wu D; Liu L
Theranostics; 2020; 10(23):10434-10447. PubMed ID: 32929358
[No Abstract] [Full Text] [Related]
18. Tramadol suppresses growth of orthotopic liver tumors via promoting M1 macrophage polarization in the tumor microenvironment.
Wang L; Guo W; Guan H; Yan N; Cai X; Zhu L
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4205-4218. PubMed ID: 38041778
[TBL] [Abstract][Full Text] [Related]
19. ATRA sensitized the response of hepatocellular carcinoma to Sorafenib by downregulation of p21-activated kinase 1.
Wang K; Qiu X; Zhang Z; Xu H; Tan Y; Su R; Gao F; Zhuo J; Li W; Lian Z; He H; Xu X
Cell Commun Signal; 2023 Aug; 21(1):193. PubMed ID: 37537668
[TBL] [Abstract][Full Text] [Related]
20. Co-delivery of plantamajoside and sorafenib by a multi-functional nanoparticle to combat the drug resistance of hepatocellular carcinoma through reprograming the tumor hypoxic microenvironment.
Zan Y; Dai Z; Liang L; Deng Y; Dong L
Drug Deliv; 2019 Dec; 26(1):1080-1091. PubMed ID: 31735093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
